Back
Rocket Pharmaceuticals Vs. Spyre Therapeutics Industry Stock Comparison
Sell
17
RCKT
Rocket Pharmaceuticals
Last Price:
$11.59
Seasonality Move:
-13.26%
Sell
28
SYRE
Spyre Therapeutics
Last Price:
$23.89
Seasonality Move:
27.42%
Sell
17
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
-
The current Rocket Pharmaceuticals [RCKT] share price is $11.58. The Score for RCKT is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
RCKT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
28
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
-
The current Spyre Therapeutics [SYRE] share price is $23.89. The Score for SYRE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $11.58Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $23.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight buying pressure.
RCKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.01 | Sell |
Relative Strength Index (14 RSI): | 29.05 | Sell |
Chaikin Money Flow: | 980346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.26 - 14.14) | Sell |
Bollinger Bands (100): | (14.41 - 19.73) | Sell |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.84 | Sell |
Relative Strength Index (14 RSI): | 36.71 | Sell |
Chaikin Money Flow: | 155695 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.73 - 28.23) | Sell |
Bollinger Bands (100): | (25.32 - 32.44) | Sell |
RCKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.04 | Sell |
20-day SMA: | 13.16 | Sell |
50-day SMA: | 15.13 | Sell |
200-day SMA: | 20.34 | Sell |
8-day EMA: | 12.05 | Sell |
20-day EMA: | 13 | Sell |
50-day EMA: | 14.74 | Sell |
200-day EMA: | 18.97 | Sell |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.29 | Sell |
20-day SMA: | 26.14 | Sell |
50-day SMA: | 30.27 | Sell |
200-day SMA: | 31.23 | Sell |
8-day EMA: | 24.39 | Sell |
20-day EMA: | 26.13 | Sell |
50-day EMA: | 28.3 | Sell |
200-day EMA: | 28.36 | Sell |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.41 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.85 per share, and an increase next year of $0.14 per share.
Rocket Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |